Concepedia

Jingxuan Wei

JW

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2024

Affiliations

China Pharmaceutical University(Current)

Jingxuan Wei is an author at China Pharmaceutical University specializing in sorafenib therapy, hepatocellular carcinoma pharmacotherapy, and hepatocellular carcinoma.

ORCID

Publications per year

2024–2024

1

Publications

1

Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China

Jingxuan Wei, Kai Xu, Yingtao Lin et al. · International Journal of Clinical Pharmacy · 2024 · 15 citations

, , +15

1–1 of 1